The protection with nothing behind it
Capital relief bought with an unfunded promise is only as good as the promise, and the whole point of the structure is that nobody has to fund it until the day everything else is going wrong too.
Insurers signed up to cover the risk of default on €4.7bn of synthetic risk transfers in 2025, up from €2.7bn in 2024, according to survey data from the International Association of Credit Portfolio Managers reported by the FT. That sits inside a European bank risk-transfer market that shifted €579bn of credit risk last year, on Barclays' numbers. So the insurers are a sliver. The sliver doubled. Here is the mechanism. In a significant risk transfer, a bank keeps a pool of loans on its books but sells the first losses on that pool to an outside investor for a fee. The regulator then lets the bank hold less capital against those loans, so it can lend more. When a hedge fund or a credit fund takes that risk, it posts collateral into an account for the life of the deal — the money is there. When a property and casualty insurer takes it, it does not. It writes the cover unfunded, backed by its rating and its balance sheet. Regulators permit this on the reasoning that bank default risk is uncorrelated with the hurricanes and cyber attacks these insurers otherwise underwrite. That is true in almost every year. It is not true in the year the protection is actually needed. Munich Re, The Fidelis Partnership and AIG-backed Convex are among the names writing it. Fitch's Monsur Hussain put the comparison plainly to the FT: credit default swaps are unfunded credit protection, and this is "essentially the same technology", though he added that AIG's volumes were far larger than anything European insurers are doing now. The volumes keep growing. Crescent Capital expects SRT sales to hit a record $45bn this year against $41bn in 2025; AIB is preparing one on €2.5bn of project finance loans, brokered by Howden, worth 25-30bp of core capital.